27/09/2022

INTRODUCING BIODGRAFT: A SOLUTION FOR LIFE

PRESS RELEASE  September 27, 2022 BioDGraft, an NLC venture, sets out to eliminate the need for vein harvesting in bypass surgeries, proposing a solution…

Read more
08/09/2022

INTRODUCING AIDO: BUILDING THE FUTURE PLATFORM FOR INTERVENTIONAL ENDOSCOPY

PRESS RELEASE   September 8, 2022 AIDO, an NLC venture, has made it its mission to bring more control to physicians performing endoscopic procedures and…

Read more
22/08/2022

NLC Collaborates with FFUND and ttopstart to accelerate growth of healthtech ventures

PRESS RELEASE AUGUST 22, 2022 NLC – The European Healthtech Venture Builder, FFUND and ttopstart partner to accelerate the growth of life-saving healthcare ventures…

Read more
02/08/2022

Haermonics Series A funding offers Pure™ promise for future heart surgery patients

Eindhoven, the Netherlands, August 2, 2022 Haermonics, a clinical-stage breakthrough medtech company, has successfully closed a 4.3 M Series-A financing round with an investment…

Read more
18/07/2022

Introducing AETHERUS: offering rapid relief to those suffering from breathlessness

PRESS RELEASE  July 15, 2022 AETHERUS, an NLC venture, sets out to improve the quality of life of patients suffering from Chronic Obstructive Pulmonary…

Read more
14/06/2022

Bright times ahead for SuperSeton

PRESS RELEASE May 2022 For the second year in a row, SuperSeton has been selected as one of 29 initiatives to join the EITHealth…

Read more
23/05/2022

Allergios closes their latest round of seed financing

This spring, the seeds are flying for Allergios Allergios – a biomedical start-up with an innovative allergy test that produces unprecedented accurate results –…

Read more
26/04/2022

Investment in ARNE helps neonatologists treat newborn babies

PRESS RELEASE April 26, 2022 ARNE B.V. has raised financing from Oost NL and venture builder NLC. ARNE supplies smart software with which neonatologists…

Read more
20/04/2022

Charles River Laboratories and NLC Collaborate

PRESS RELEASE April 2022 NLC – The European Healthtech Venture Builder and Charles River Laboratories team up to drive drug discovery projects towards finding…

Read more
14/03/2022

Scinvivo secures 1 Million investment for in human clinical trials & CE

Press Release  Eindhoven, March 10th, 2022 Scinvivo 1 million investment secured towards in human clinical trials & CE for game-changing cancer diagnostics Scinvivo, a…

Read more
25/02/2022

Hemeo raises €675,000 in an oversubscribed seed equity round

Hemeo announces the successful closure of its first equity finance round. Raising €675,000, it has been substantially oversubscribed, highlighting the strong interest raised by…

Read more
24/01/2022

Bilihome successfully closes an investment round for smart, wearable light therapy for newborns with jaundice

PRESS RELEASE Bilihome successfully closes an investment round for smart, wearable light therapy for newborns with jaundice Margret Huenerbein, m.huenerbein@bilihome.org, www.bilihome.org Nijkerk, the Netherlands…

Read more